Loss of skeletal muscle is a characteristic feature and leads to poor prognosis in cancer-associated cachexia; there is a downregulation of MEF-2C (at the mRNA and protein levels) in cachexia which leads to the loss of skeletal muscle architecture and mitochondrial integrity as observed by electron microscopy. This evidence concerns the gene MEF2C and cancer.